Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities

In the updated diagnostic criteria for arrhythmogenic cardiomyopathy (ACM) (2020 and 2022), magnetic resonance imaging (MRI) has become the preferred method for cardiac imaging. This is due to advances in MRI and the accumulation of evidence on its reliability. Non-invasive assessment of myocardial...

Full description

Saved in:
Bibliographic Details
Main Authors: S A. Aleksandrova, E. Yu. Glazkova, E. Z. Golukhova
Format: Article
Language:Russian
Published: «FIRMA «SILICEA» LLC 2024-12-01
Series:Российский кардиологический журнал
Subjects:
Online Access:https://russjcardiol.elpub.ru/jour/article/view/6118
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849340896984694784
author S A. Aleksandrova
E. Yu. Glazkova
E. Z. Golukhova
author_facet S A. Aleksandrova
E. Yu. Glazkova
E. Z. Golukhova
author_sort S A. Aleksandrova
collection DOAJ
description In the updated diagnostic criteria for arrhythmogenic cardiomyopathy (ACM) (2020 and 2022), magnetic resonance imaging (MRI) has become the preferred method for cardiac imaging. This is due to advances in MRI and the accumulation of evidence on its reliability. Non-invasive assessment of myocardial fibrotic replacement using late gadolinium enhancement techniques is a key innovation, which, along with histology data, was included in the category of "structural changes". The technique has demonstrated significance in identifying various ACM phenotypes (primarily the left ventricular one), in differential diagnostics and family screening of the disease. The relevance of MRI data has been proven in predicting the risks of adverse cardiovascular events, including sudden cardiac death. Some MRI techniques, such as T1 mapping and myocardial strain assessment, are under study, but they have already shown promise in studies on small groups. Obtaining and interpreting cardiac MRI data in patients with ACM requires not only standardized protocols and high experience of a radiologist, but also teamwork with cardiologists. The article summarizes the current capabilities of MRI in ACM and provides a practical approach to diagnosis and risk stratification.
format Article
id doaj-art-244c82b73db34ce8a2dea8e4973075a0
institution Kabale University
issn 1560-4071
2618-7620
language Russian
publishDate 2024-12-01
publisher «FIRMA «SILICEA» LLC
record_format Article
series Российский кардиологический журнал
spelling doaj-art-244c82b73db34ce8a2dea8e4973075a02025-08-20T03:43:46Zrus«FIRMA «SILICEA» LLCРоссийский кардиологический журнал1560-40712618-76202024-12-012911S10.15829/1560-4071-2024-61184223Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilitiesS A. Aleksandrova0E. Yu. Glazkova1E. Z. Golukhova2Bakulev National Medical Research Center of Cardiovascular SurgeryBakulev National Medical Research Center of Cardiovascular SurgeryBakulev National Medical Research Center of Cardiovascular SurgeryIn the updated diagnostic criteria for arrhythmogenic cardiomyopathy (ACM) (2020 and 2022), magnetic resonance imaging (MRI) has become the preferred method for cardiac imaging. This is due to advances in MRI and the accumulation of evidence on its reliability. Non-invasive assessment of myocardial fibrotic replacement using late gadolinium enhancement techniques is a key innovation, which, along with histology data, was included in the category of "structural changes". The technique has demonstrated significance in identifying various ACM phenotypes (primarily the left ventricular one), in differential diagnostics and family screening of the disease. The relevance of MRI data has been proven in predicting the risks of adverse cardiovascular events, including sudden cardiac death. Some MRI techniques, such as T1 mapping and myocardial strain assessment, are under study, but they have already shown promise in studies on small groups. Obtaining and interpreting cardiac MRI data in patients with ACM requires not only standardized protocols and high experience of a radiologist, but also teamwork with cardiologists. The article summarizes the current capabilities of MRI in ACM and provides a practical approach to diagnosis and risk stratification.https://russjcardiol.elpub.ru/jour/article/view/6118arrhythmogenic cardiomyopathydiagnostic criteriamagnetic resonance imaginglate gadolinium enhancementlate accumulation of gadolinium contrast agentmyocardial fibrosis
spellingShingle S A. Aleksandrova
E. Yu. Glazkova
E. Z. Golukhova
Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities
Российский кардиологический журнал
arrhythmogenic cardiomyopathy
diagnostic criteria
magnetic resonance imaging
late gadolinium enhancement
late accumulation of gadolinium contrast agent
myocardial fibrosis
title Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities
title_full Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities
title_fullStr Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities
title_full_unstemmed Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities
title_short Cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy: evolving diagnostic criteria and new capabilities
title_sort cardiac magnetic resonance imaging in arrhythmogenic cardiomyopathy evolving diagnostic criteria and new capabilities
topic arrhythmogenic cardiomyopathy
diagnostic criteria
magnetic resonance imaging
late gadolinium enhancement
late accumulation of gadolinium contrast agent
myocardial fibrosis
url https://russjcardiol.elpub.ru/jour/article/view/6118
work_keys_str_mv AT saaleksandrova cardiacmagneticresonanceimaginginarrhythmogeniccardiomyopathyevolvingdiagnosticcriteriaandnewcapabilities
AT eyuglazkova cardiacmagneticresonanceimaginginarrhythmogeniccardiomyopathyevolvingdiagnosticcriteriaandnewcapabilities
AT ezgolukhova cardiacmagneticresonanceimaginginarrhythmogeniccardiomyopathyevolvingdiagnosticcriteriaandnewcapabilities